Extensive Coronary Thrombosis as a Sequelae of COVID-19 Presenting as a STEMI.
| Autor: | Madkour M; Internal Medicine, University of California Riverside School of Medicine/Riverside Community Hospital, Riverside, USA., Savoj J; Cardiology, University of California Riverside School of Medicine/Riverside Community Hospital, Riverside, USA., Iftikhar S; Cardiology, University of California Riverside School of Medicine/Riverside Community Hospital, Riverside, USA., Waked A; Interventional Cardiology, Riverside Community Hospital, Riverside, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2021 May 26; Vol. 13 (5), pp. e15258. Date of Electronic Publication: 2021 May 26. |
| DOI: | 10.7759/cureus.15258 |
| Abstrakt: | Thrombotic complications, in particular ST-elevation myocardial infarction (STEMI), have been described in active Coronavirus disease 2019 (COVID-19) cases. This is a result of systemic inflammation that often leads to endothelial activation, microvascular thrombosis and a hypercoagulable state. However, it is unknown how long patients who have cleared the COVID-19 infection remain at risk for coronary thrombosis as a sequela of disease burden. We present a case of a patient who presented three to four weeks following the initial infection. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Madkour et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|